User profiles for PIERRE COCHAT
 | Pierre CochatProfesseur des Universités - Praticien Hospitalier Verified email at chu-lyon.fr Cited by 22624 |
[HTML][HTML] Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1
…, MJ Koren, WD O'Riordan, P Cochat… - New England journal …, 2021 - Mass Medical Soc
Background Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by hepatic
overproduction of oxalate that leads to kidney stones, nephrocalcinosis, kidney failure, and …
overproduction of oxalate that leads to kidney stones, nephrocalcinosis, kidney failure, and …
Primary hyperoxaluria
P Cochat, G Rumsby - New England Journal of Medicine, 2013 - Mass Medical Soc
Primary Hyperoxaluria | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters
…, P Braillon, L David, P COCHAT… - The Journal of …, 1990 - academic.oup.com
The bone mineral density (BMD) of the lumbar spine (L1-L4) was measured by dual energy
x-ray absorptiom-etry (Hologic QDR 1000) in 135 healthy Caucasian children, aged 1–15 yr, …
x-ray absorptiom-etry (Hologic QDR 1000) in 135 healthy Caucasian children, aged 1–15 yr, …
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
P Cochat, SA Hulton, C Acquaviva… - Nephrology Dialysis …, 2012 - academic.oup.com
Primary hyperoxaluria Type 1 is a rare autosomal recessive inborn error of glyoxylate
metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate …
metabolism, caused by a deficiency of the liver-specific enzyme alanine:glyoxylate …
Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
…, B Ranchin, N Fabien, P Cochat… - Nature …, 2009 - nature.com
Studies have suggested involvement of interleukin 17 (IL-17) in autoimmune diseases, although
its effect on B cell biology has not been clearly established. Here we demonstrate that IL…
its effect on B cell biology has not been clearly established. Here we demonstrate that IL…
Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities
…, B Royer-Pokora, E Wühl, P Cochat… - Human molecular …, 2004 - academic.oup.com
Congenital nephrotic syndrome (CNS) is clinically and genetically heterogeneous, with
mutations in WT1, NPHS1 and NPHS2 accounting for part of cases. We recently delineated a …
mutations in WT1, NPHS1 and NPHS2 accounting for part of cases. We recently delineated a …
[HTML][HTML] Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
…, Y Pirson, JP Grunfeld, P Niaudet, P Cochat… - Kidney international, 2012 - Elsevier
Alport syndrome inevitably leads to end-stage renal disease and there are no therapies
known to improve outcome. Here we determined whether angiotensin-converting enzyme …
known to improve outcome. Here we determined whether angiotensin-converting enzyme …
[HTML][HTML] ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
…, P Nitschké, C Bole-Feysot, P Cochat… - The Journal of …, 2013 - Am Soc Clin Investig
Identification of single-gene causes of steroid-resistant nephrotic syndrome (SRNS) has
furthered the understanding of the pathogenesis of this disease. Here, using a combination of …
furthered the understanding of the pathogenesis of this disease. Here, using a combination of …
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study
…, MP Lavocat, G Bourdat-Michel, F Nobili, P Cochat - Pediatric …, 2009 - Springer
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome was retrospectively
studied in 78 children in eight centers for the past 20 years. Median age at onset was 4.4 years …
studied in 78 children in eight centers for the past 20 years. Median age at onset was 4.4 years …